" class="no-js "lang="en-US"> Freenome Archives - Medtech Alert
Thursday, March 30, 2023

Sort by:

Date

Top Post

NHS Slashes Longest Elective and Cancer Patient Waiting Lists

The number of people waiting over 18 months for NHS care has fallen again despite […]

Largest Clinical Study Validating A Blood-based Colorectal Screening Test Completes Enrollment

Freenome, a privately held biotech company, announced the completion of enrollment for PREEMPT CRC, the […]

Lance Baldo Joins Freenome as Chief Medical Officer

Freenome, a privately held biotech company, announced today that Lance Baldo, M.D. has joined the […]

Freenome Launches The Vallania Study For The Early Detection Of Multiple Cancers

Freenome, a privately held biotech company, today announced the initiation of Vallania, a clinical study […]

Freenome Presents Research Highlighting its Multiomics Blood Testing Platform in PREEMPT CRC

Freenome, a privately held biotech company, presented at the American Society of Clinical Oncology Gastrointestinal […]

Significant Investment Accelerates Freenome's Multiomics Platform for the Early Detection of Cancer

Freenome, a privately held biotech company, announced today that Roche has made an investment of $290 […]

Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection

Freenome, a privately held biotech company, today announced a Series D funding of $300 million. […]

Freenome Shows Continued Leadership in Colorectal Cancer Research

Freenome, a privately held biotech company, presented new research at the American College of Gastroenterology […]

New Study Finds Freenome ’s Multiomics Approach Successful in Detecting Pancreatic Cancer

Freenome, a privately-held biotech company, presented new research today at the American Association of Cancer […]

  1. Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Read more
  2. Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Read more
  3. Implantica Launches RefluxStop™ in Italy Read more
  4. Granular Therapeutics to Accelerate Development of Next-Generation Pipeline for Treating Mast Cell Driven Diseases Read more
  5. Xeris Biopharma Appoints Ricki Fairley to Board of Directors Read more